Lifecore Biomedical, Inc. (LFCR)

Lifecore Biomedical Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Lifecore Biomedical stock has a target of 5.50, which predicts a 7.42% increase from the current stock price of 5.12.

Price Target: $5.50 (+7.42%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$5.50	$5.50	$5.50	$5.50
Change	+7.42%	+7.42%	+7.42%	+7.42%

* Price targets were last updated on Mar 27, 2026.

Analyst Ratings

The average analyst rating for Lifecore Biomedical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	1	1	1	1	0	0
Buy	1	1	1	1	2	2
Hold	2	2	2	2	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Michael Petusky Barrington Research	Barrington Research	Buy Maintains $5.5	Buy	Maintains	$5.5	+7.42%	Mar 27, 2026
Michael Petusky Barrington Research	Barrington Research	Buy Maintains $5.5	Buy	Maintains	$5.5	+7.42%	Mar 24, 2026
Michael Petusky Barrington Research	Barrington Research	Hold → Buy Upgrades $5.5	Hold → Buy	Upgrades	$5.5	+7.42%	Mar 17, 2026
Paul Knight Keybanc	Keybanc	Hold Initiates n/a	Hold	Initiates	n/a	n/a	Sep 4, 2025
Max Smock William Blair	William Blair	Buy Initiates n/a	Buy	Initiates	n/a	n/a	May 21, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

124.88M

Decreased by -3.54%

from 129.46M

Revenue Next Year

131.17M

Increased by 5.04%

from 124.88M

EPS This Year

-0.91

from -0.93

EPS Next Year

-0.93

from -0.91

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2025	FY 2026	FY 2027
Period Ending	May 29, 2022	May 28, 2023	May 26, 2024	May 25, 2025	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	111.27M	103.27M	128.26M	128.87M	129.46M	124.88M	131.17M
Revenue Growth	10.31%	-7.19%	24.20%	0.47%	0.46%	-3.54%	5.04%
EPS	-3.97	-3.32	0.33	-1.27	-0.93	-0.91	-0.93
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030	2031	2032
High	129.1M	137.2M
Avg	124.9M	131.2M
Low	119.4M	122.8M

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030	2031	2032
High	-0.3%	9.9%
Avg	-3.5%	5.0%
Low	-7.8%	-1.7%

EPS Forecast

EPS	2026	2027	2028
High	-0.93	-0.96
Avg	-0.91	-0.93
Low	-0.87	-0.89

EPS Growth

EPS Growth	2026	2027	2028
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.